Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DCPH | AMGN | BMY | VRTX | GILD |
| Company | Deciphera Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 25.56 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 25.61 | 289.84 | 58.22 | 455.43 | 89.34 |
| Low | 25.56 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 25.59 | 287.95 | 58.14 | 446.81 | 89.23 |
| Change | +0.02 | +0.08 | +0.26 | -4.42 | +0.60 |
| % Change | +0.08% | +0.03% | +0.45% | -0.98% | +0.68% |
| Volume | 1,596,000 | 849,686 | 2,325,219 | 462,574 | 1,139,688 |
| 20-Day Average Volume | 1,368,160 | 2,784,041 | 12,130,842 | 1,290,313 | 7,378,613 |
| Previous Close | 25.57 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.51 | 307.32 | 55.91 | 479.10 | 90.86 |
| 20-Day Raw Stochastic | 91.30% | 23.52% | 66.56% | 3.32% | 23.89% |
| 20-Day Relative Strength | 81.53% | 34.92% | 60.15% | 40.14% | 52.23% |
| Weighted Alpha | +31.26 | +0.98 | +25.31 | +17.04 | +24.87 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.12% since 06/03/24 | -2.70% since 11/14/24 | -0.89% since 11/14/24 | -7.51% since 11/14/24 | -3.22% since 11/14/24 |
| Low | 25.55 on 06/06/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 25.61 on 06/10/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.91% since 05/10/24 | -9.09% since 10/21/24 | +11.24% since 10/21/24 | -6.37% since 10/21/24 | +3.31% since 10/21/24 |
| Low | 25.38 on 05/13/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 25.61 on 06/10/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +51.06% since 03/08/24 | -12.52% since 08/21/24 | +19.69% since 08/21/24 | -7.92% since 08/21/24 | +18.65% since 08/21/24 |
| Low | 14.00 on 04/25/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 25.61 on 06/10/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +72.91% since 12/08/23 | -8.54% since 05/21/24 | +37.17% since 05/21/24 | +1.27% since 05/21/24 | +32.47% since 05/21/24 |
| Low | 13.25 on 01/18/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 25.61 on 06/10/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,212,921 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 86,476 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 163,360,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -194,940,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 45,000,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -45,080,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.19 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 05/10/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/15/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |